Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The discovery of glycine and related amino acid-based factor Xa inhibitors

Journal Article · · Bioorgan. Med. Chem.

Herein, we report on the identification of three potent glycine and related amino acid-based series of FXa inhibitors containing a neutral P1 chlorophenyl pharmacophore. A X-ray crystal structure has shown that constrained glycine derivatives with optimized N-substitution can greatly increase hydrophobic interactions in the FXa active site. Also, the substitution of a pyridone ring for a phenylsulfone ring in the P4 sidechain resulted in an inhibitor with enhanced oral bioavailability.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
USDOE
OSTI ID:
1007765
Journal Information:
Bioorgan. Med. Chem., Journal Name: Bioorgan. Med. Chem. Journal Issue: (13) ; 2006 Vol. 14; ISSN 0968-0896; ISSN BMECEP
Country of Publication:
United States
Language:
ENGLISH

Similar Records

SAR and X-ray Structures of Enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and Cyclohexyldiamine Derivativies as Inhibitors of Coagulation Factor Xa
Journal Article · Sun Dec 31 23:00:00 EST 2006 · BioOrganic and Medicinal Chemistry Letters · OSTI ID:930032

Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors
Journal Article · Wed Apr 01 00:00:00 EDT 2015 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1404973

Nonbenzamidine acylsulfonamide tissue factor–factor VIIa inhibitors
Journal Article · Sun Sep 01 00:00:00 EDT 2013 · Bioorganic & Medicinal Chemistry Letters · OSTI ID:1347765